经股动脉逆行入路与上肢顺行入路在复杂主动脉腔内治疗中利用即用型内分支内移植物进行靶血管插管的效果相当:意大利E-nside内移植物分支注册研究(INBREED)
这项全国性、研究者发起的多中心观察性研究前瞻性收集了2020年9月至2024年2月共166例使用E-nside即用型内分支胸腹主动脉内移植物的手术,其中128例(77.1%)采用上肢顺行入路、38例(22.9%)采用股动脉逆行入路进行靶血管插管。逆行入路平均手术时间更长(313±155分钟 vs 282±90分钟,p=.006),但30天靶血管相关技术成功率(94.7% vs 94.5%,p=.96)和12个月生存率(91.1% vs 87.7%,p=.92)无显著差异。结论认为完全经股动脉逆行入路进行内分支靶血管插管有效且未伴随任何神经事件。
要点
- 逆行入路平均手术时间长于顺行入路(313±155分钟 vs 282±90分钟,p=.006)。
- 30天靶血管相关技术成功率顺行组94.5%、逆行组94.7%(p=.96)。
- 顺行组术后卒中6例(4.7%),逆行组0例(p=.17)。
核心结论
- 完全经股动脉逆行入路进行内分支靶血管插管有效,且未伴随任何神经事件。
研究设计与样本
- 全国性、研究者发起的多中心观察性研究,前瞻性收集E-nside内移植物注册数据,按靶血管插管入路分为顺行上肢组128例(77.1%)和逆行股动脉组38例(22.9%),遵循STROBE指南。
主要发现
- 逆行组平均手术时间长于顺行组(313±155分钟 vs 282±90分钟,p=.006),透视时间、剂量面积乘积和对比剂注射量相似。
- 桥接支架选择无统计学显著差异(仅球囊扩张式69.4% vs 73.7%;仅自膨式12.9% vs 7.9%;混合配置17.7% vs 18.4%;p=.68)。
- 顺行组术后卒中6例(4.7% vs 0%;p=.17)。
- 30天靶血管相关技术成功率顺行组94.5%、逆行组94.7%(p=.96)。
- 平均随访14.4±11.3个月(中位12.5个月),12个月总生存率顺行组87.7%(95%CI 81-95)vs 逆行组91.1%(95%CI 82-100;log rank=.009,p=.92);竞争风险分析显示两组1年靶血管不稳定性和靶血管相关再干预在患者层面和靶血管层面均相似。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The aim of this study was to assess the results of an off the shelf inner branched thoraco-abdominal endograft for treating aortic pathologies, with a specific focus on comparing outcomes between antegrade and retrograde approaches for target vessel (TV) cannulation. METHODS: This was a national, physician initiated, multicentre, observational study. Data from a registry on patients treated with the E-nside endograft were gathered prospectively. Patients were divided into two groups based on the type of endovascular approach for TV cannulation. The study adhered to the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guidelines. RESULTS: From September 2020 to February 2024, 166 procedures were collected, of which 128 (77.1%) used an antegrade upper extremity approach to TV cannulation, while 38 (22.9%) employed a retrograde femoral approach. There were no statistically significant differences in terms of bridging stent choice (balloon expandable only, 69.4% vs. 73.7%; self expandable only, 12.9% vs. 7.9%; mixed configurations, 17.7% vs. 18.4%; p = .68). The mean operation time ± standard deviation was longer for the retrograde approach (282 ± 90 minutes vs. 313 ± 155 minutes; p = .006), but fluoroscopy time, dose area product, and the volume of contrast injected were similar. Six cases of post-operative stroke were reported in the antegrade group (4.7% vs. 0%; p = .17). The 30 day TV related technical success was 94.5% and 94.7%, respectively, for antegrade and retrograde approaches (p = .96). Mean follow up was 14.4 ± 11.3 months (median 12.5 months). Kaplan-Meier estimates (with 95% confidence interval [CI]) at twelve months revealed similar overall survival (87.7%, 95% CI 81 - 95% vs. 91.1%, 95% CI 82 - 100%; log rank = .009, p = .92). Competing risk analysis revealed similar one year estimates of TV instability and TV related re-intervention between groups both in patient centred and TV centred analyses. CONCLUSION: A total transfemoral retrograde approach for TV cannulation of inner branches proved to be effective and was not associated with any neurological events.
引用
- Esposito D, Bastianon M, Simonte G, et al. Target Vessel Cannulation with a Transfemoral Retrograde Approach Equals Antegrade Approach from the Upper Extremity in Complex Aortic Treatment with Off the Shelf Inner Branched Endografts in the Italian Branched Registry of E-nside Endograft (INBREED). Eur J Vasc Endovasc Surg. 2025. PMID: 39971094. doi:10.1016/j.ejvs.2025.02.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。